Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Proactive following the release of full year results for 2022.
Barder says that despite losses, revenues "are now rapidly coming over the horizon" and he suggests "the last two years have been very very good for us".
He adds that he's "confident of getting FDA approval for MED3000 this quarter"